Overview

A Research Study of MK0633 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0633-009)(COMPLETED)

Status:
Completed

Trial end date:
2009-03-01

Target enrollment:

Participant gender:

Summary

A clinical study to evaluate the efficacy and safety of MK0633 in patients with Chronic Obstructive Pulmonary Disease (COPD).

Phase:

Phase 2

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.